Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
146.66B
Market cap146.66B
Price-Earnings ratio
13.68
Price-Earnings ratio13.68
Dividend yield
6.64%
Dividend yield6.64%
Average volume
35.34M
Average volume35.34M
High today
$26.11
High today$26.11
Low today
$25.77
Low today$25.77
Open price
$25.91
Open price$25.91
Volume
20.97M
Volume20.97M
52 Week high
$30.43
52 Week high$30.43
52 Week low
$20.92
52 Week low$20.92

PFE News

TipRanks 2h
Pfizer’s Migraine Study: Real-World Insights on Nurtec vs. Triptans

Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 2d
Pfizer’s Latest Study on NSCLC Treatment: A Potential Game-Changer?

Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

Seeking Alpha 2d
Pfizer sued by Enanta in EU over patent infringement related to COVID pill

Enanta Pharmaceuticals (NASDAQ:ENTA) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE) and some of its subsidiaries, alleging that the...

Pfizer sued by Enanta in EU over patent infringement related to COVID pill

Analyst ratings

62%

of 26 ratings
Buy
34.6%
Hold
61.5%
Sell
3.8%

More PFE News

TipRanks 2d
Enanta Pharmaceuticals Sues Pfizer Over Patent Infringement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 2d
Enanta files EU patent infringement suit against Pfizer

Enanta (ENTA) announced that it has filed suit in the Unified Patent Court of the European Union against Pfizer (PFE) and certain of its subsidiaries, seeking a...

TipRanks 4d
Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for individuals aged 6...

Benzinga 7d
Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease

Pfizer Inc. PFE on Friday released results from the Phase 3 THRIVE-131 study evaluating inclacumab, an investigational P-selectin inhibitor, in patients 16 year...

Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.